Cleared Traditional

K243239 - Lung AI (LAI001) (FDA 510(k) Clearance)

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K243239 · Exo, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2025
Decision
196d
Days
Class 2
Risk

K243239 is an FDA 510(k) clearance for the Lung AI (LAI001). Classified as Analyzer, Medical Image (product code MYN), Class II - Special Controls.

Submitted by Exo, Inc. (Santa Clara, US). The FDA issued a Cleared decision on April 24, 2025 after a review of 196 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2070 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Exo, Inc. devices

Submission Details

510(k) Number K243239 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 10, 2024
Decision Date April 24, 2025
Days to Decision 196 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
89d slower than avg
Panel avg: 107d · This submission: 196d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MYN Analyzer, Medical Image
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2070
Definition For Information On The Myn Device, Please See: Https://www.federalregister.gov/documents/2020/01/22/2020-00494/radiology-devices-reclassification-of-medical-image-analyzers
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - MYN Analyzer, Medical Image

All 35
Devices cleared under the same product code (MYN) and FDA review panel - the closest regulatory comparables to K243239.
qXR-Detect
K251934 · Qure.Ai Technologies · Jan 2026
Diagnocat
K252934 · DGNCT, LLC · Jan 2026
DS Core Detect
K253009 · Dentsply Sirona, Inc. · Jan 2026
DTX Studio Assist
K252086 · Nobel Biocare C/O Medicim NV · Nov 2025
Second Opinion® Panoramic
K250525 · Pearl, Inc. · Nov 2025
SugarBug (1.x)
K250264 · Bench7, Inc. · Nov 2025